REQUEST A DEMO
Total
USD $0.00
Search more companies

Cstone Pharmaceuticals (China)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Full name: Cstone Pharmaceuticals Profile Updated: July 06, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

CStone Pharmaceuticals is a biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients worldwide. The company has a pipeline of 14 drug candidates with a strategic emphasis on immuno-oncology combination therapies and positions itself as a partner for multinational pharmaceutical/biotech companies to develop drugs in China and the Asia Pacific region. CStone has a management team with clinical development and translational medicine as its core competence.

Headquarters
1000 Zhangheng Road, Building 25, Pudong New District
Shanghai; Shanghai; Postal Code: 201203

Contact Details: Purchase the Cstone Pharmaceuticals report to view the information.

Website: http://www.cstonepharma.com

Basic Information
Total Employees:
Purchase the Cstone Pharmaceuticals report to view the information.
Outstanding Shares:
Purchase the Cstone Pharmaceuticals report to view the information.
Financial Auditors:
Purchase the Cstone Pharmaceuticals report to view the information.
Incorporation Date:
2015
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
24.71%
Purchase this report to view the information.
12.01%
Purchase this report to view the information.
9.77%
Purchase this report to view the information.
8.27%
Purchase this report to view the information.
4.08%
Subsidiaries
Cstone Australia (Australia)
100%
Cstone Hk (Hong Kong SAR, China)
100%
Cstone Medicine (Bvi) Limited (United Kingdom)
100%
Company Performance
Financial values in the chart are available after Cstone Pharmaceuticals report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-2.8%
Total operating revenue
-3.82%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-7.69%
Total equity
-22.54%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
30.87%
Quick Ratio
-0.06%
Cash Ratio
-0.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?